David Gray
David joined the Drug Discovery Unit (DDU) in 2010. As Head of Biology, David contributes to the scientific and strategic direction of the DDU. He has responsibility for the quality of output of the compound screening campaigns and underpinning biological characterisation of the hit molecules including the integrated compound and data management functions. His role encompasses the development of strategies for people, facilities, equipment and IT that are required to maintain the DDU at the leading edge in providing biological support to drug discovery programs. Prior to the DDU, David was Director, Screening and Compound Profiling at GlaxoSmithKline.
